tiprankstipranks
Nektar Therapeutics (DE:ITH0)
XETRA:ITH0
Germany Market
ITH0
Nektar Therapeutics
RESEARCH TOOLSreports

Nektar Therapeutics (ITH0) Stock News & Sentiment

1 Followers
Nektar Therapeutics’ Earnings Call Highlights Rezpeg Momentum
Premium
Company Announcements
Nektar Therapeutics’ Earnings Call Highlights Rezpeg Momentum
24d ago
NKTR
Nash Reiterates Buy on Nektar, Citing Strong Cash Position and Rezpegaldesleukin Progress; Keeps $153 Price Target Unchanged
Premium
Ratings
Nash Reiterates Buy on Nektar, Citing Strong Cash Position and Rezpegaldesleukin Progress; Keeps $153 Price Target Unchanged
28d ago
NKTR
Nektar: Strong Cash Runway and Rezpeg Momentum Support Unchanged $185 Price Target and Buy Rating
Premium
Ratings
Nektar: Strong Cash Runway and Rezpeg Momentum Support Unchanged $185 Price Target and Buy Rating
28d ago
NKTR
Nektar Therapeutics Initiated at Buy on Rezpeg’s Advancing Pivotal Programs and Solid Cash Runway
Premium
Ratings
Nektar Therapeutics Initiated at Buy on Rezpeg’s Advancing Pivotal Programs and Solid Cash Runway
28d ago
NKTR
Nektar: Rezpeg’s Advancing Phase 3 Programs and Disease‑Modifying Potential Support Buy/High Risk Rating with Price Target Maintained at $151
Premium
Ratings
Nektar: Rezpeg’s Advancing Phase 3 Programs and Disease‑Modifying Potential Support Buy/High Risk Rating with Price Target Maintained at $151
1M ago
NKTR
NKTR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NKTR Earnings this Week: How Will it Perform?
1M ago
NKTR
Nektar’s Phase 3 Eczema Trial Moves Forward: What Investors Should Watch
Premium
Company Announcements
Nektar’s Phase 3 Eczema Trial Moves Forward: What Investors Should Watch
1M ago
NKTR
More DE:ITH0 News >

ITH0 News on the Web

Stonepine Capital Management, LLC Buys Femasys Inc (FEMY) -- Shares Look 70% Undervalued on GF Value
GuruFocus News
Neutral
Stonepine Capital Management, LLC Expands Edesa Biotech Inc (EDSA) Stake with Strategic Add
GuruFocus News
Neutral
Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move
GuruFocus News
Neutral
Why Nektar Therapeutics Stock Is Suddenly Sinking
TipRanks News
Neutral
Nektar reinstated with a Neutral at JPMorgan
TipRanks News
Neutral
Nektar (NKTR) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
NKTR SWOT Analysis: Financial Challenges and Growth Potential Revealed in 10-Q Filing
GuruFocus News
Neutral
U.S. Stock Futures Mixed, Heads for a Winning Week
Zacks
Neutral

News Score - Last 7 Days

Neutral
DE:ITH0
Sector Average
Media Buzz
This Week2 articles
Weekly Average7.75 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ITH0’s Media Buzz Sentiment?
2 articles about DE:ITH0 were published this week. In an average week, 7.75 articles are published.
    What is DE:ITH0’s weekly average amount of articles?
    In an average week, 7.75 articles about DE:ITH0 are published.
      What is DE:ITH0’s News Sentiment?
      50% of articles about DE:ITH0 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SRRKScholar Rock Holding
        SMMTSummit Therapeutics
        BAYRYBayer
        ABBVAbbVie
        KURAKura Oncology
        Showing the stocks with the most bullish news sentiment over the past week